Standard Chartered CEO Apologizes for Lower Value Human Capital Remark Americans Face Higher Prices Over Memorial Day Weekend as Inflation Accelerates in April The Feds Path to Rate Cuts Narrows as CostofLiving Pressures Intensify Trump EPAs PFAS Destruction Plan Draws Industry and Health Concerns Cement Sector Faces Cost Pressures as Industry Eyes Demand Recovery and Price Hikes Coastal Erosion Threatens UK Property Values and Infrastructure Spending The Slapton Line Case MELI Q1 2026 Earnings EPS Miss Despite Strong Operational Momentum MRDN Q1 2026 Earnings Massive EPS Beat Surprises Market BTGO Q1 2026 Earnings Significant Earnings Miss Drives Stock Decline UroGen Pharma Ltd URGN Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction IMDX Q1 2026 Earnings EPS beats estimates by 55 despite revenue absence GENI Q1 2026 Earnings Widened Loss Surprises Market Yet Stock Rallies Bunge Limited BG Holds Steady Near 121 Signs of Consolidation Amid Sector Pressure Bassett Furniture BSET Holds Steady Near Resistance as Market Watches for Breakout Acurx Pharmaceuticals ACXP Nudges Higher as Stock Approaches Resistance RILYT Notes Slide 147 as Interest Rate Sensitivity Weighs on Bond Prices PROCEPT BioRobotics PRCT Holds Steady Near Support Amid Low Volatility US April Payrolls Surge Beyond Expectations Yet Underlying Weaknesses Emerge VABK Q1 2026 Earnings Steady Profitability Amid Stable Banking Operations Better Home Finance Holding Warrants BETRW Slide Sharply as Support Level Under Threat Aemetis Inc AMTX Q1 2026 Earnings EPS Misses Estimates Despite Stock Surge Genmab AS ADS GMAB Q1 2026 Earnings EPS Miss Weighs on Shares as Revenue Picture Remains Unclear EVAX Q1 2026 Earnings Wider Than Expected Loss as PreRevenue Biotech Advances Pipeline JUNS Q4 2025 Earnings Narrower Loss Surprises Yet Stock Falls on PreRevenue Path SMR Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Company Advances Technology PDS Biotechnology Q1 2026 Earnings Narrowed Loss Per Share and Clinical Progress Drive Positive Market Response CV Q1 2026 Earnings EPS Misses Estimates as Losses Widen Amid No Revenue Disclosure